Castres, France

Adrian Newman-Tancredi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adrian Newman-Tancredi

Introduction

Adrian Newman-Tancredi, an accomplished inventor based in Castres, France, has made significant strides in the field of neuroscience and pharmacology. With a total of four patents to his name, he has focused on developing innovative therapies for serious medical conditions, particularly those associated with neurological disorders.

Latest Patents

Among his latest patents, one stands out: the "Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy." This invention addresses the treatment and prevention of diseases linked to a higher risk of sudden unexpected death in epilepsy, such as Fragile X syndrome, by administering a selective 5-HT1A receptor agonist. Another notable patent is "Use of selective serotonin 5-HT receptor agonists for treating side-effects of VMAT inhibitors." This invention proposes methods to minimize the side effects induced by tetrabenazine or other vesicular monoamine transporter (VMAT) inhibitors in patients suffering from central nervous system disorders, including Huntington's disease and Parkinson's disease.

Career Highlights

Throughout his career, Adrian has collaborated with prominent organizations such as Neurolixis and Jagiellonian University Medical College, where he has contributed to groundbreaking research and development in medical treatments. His work is considered invaluable in providing new therapeutic options for patients suffering from serious neurological diseases.

Collaborations

In his journey of innovation, Adrian has worked alongside esteemed colleagues such as Mark Andrew Varney and Anna Wesolowska. Their collaborations have resulted in the advancement of vital research initiatives and innovations in the medical field.

Conclusion

Adrian Newman-Tancredi's contributions to medical science through his patents exemplify the spirit of innovation and the pursuit of knowledge. His focus on utilizing serotonin receptor agonists to tackle complex neurological disorders showcases the potential of research to enhance patient care. As he continues to invent and innovate, the impact of his work will likely resonate within the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…